• The NIH Guidelines for Human Stem Cell Research and the Role of Advocacy 1
  Alan Jakimo, J.D.

• A Survey of Ethical and Legal Issues Related to Stem Cell Research 9
  Lori P. Knowles

• Registration of Stem Cell-Based Clinical Trials: A Scientific and Ethical Imperatives 15
  Rosario M. Isasi, J.D., M.P.H.

• Federal Funding of Stem Cell Research: Past, Present and Future 22
  Larry Soler

• The Alliance for Regenerative Medicine: Securing Favorable Research, Regulatory and Reimbursement Policies to Advance Important Technologies 27
  Michael Werner, Esq.

• The Thirty Year Stem Cell Debate in the United States and the Power of Advocacy 32
  Alan Jakimo, J.D.

• Stem Cell Advocacy 2.0: A Blueprint for Change 41
  Bernard Siegel, J.D.

• The Use and Promise of Stem Cells in Drug Discovery 45
  Marcie A. Glicksman, Ph.D., Kelvin Lam, Ph.D., Maria Webb, Ph.D., G. Sitta Sittampalam, Ph.D.
  
  
• Cellular Therapy for CNS Disorders: A Translational Perspective 50
  Stephen Huhn, M.D., F.A.C.S., F.A.A.P.
  
  
• Stem Cell Retinal Replacement Therapy 57
  Jeffrey H. Stern, Ph.D., M.D., Michael Radosevich, M.D., Ph.D., Sally Temple, M.D.
  
  
• Stem Cell Therapy for Liver Disease 63
  Stuart Forbes, M.D.
  
  
• Orthobiologics: Early Adopters are Innovating the Regenerative Medicine Industry with Clinical Results 67
  Richard Kyle, M.D, Matthew Kyle, J.D., and Kyle Swartout
  
  
• Stem Cells and Diabetes: New Trends and Clinical Prospects 73
  Juan Domínguez-Bendala, MSc, Ph.D., and Camillo Ricordi, M.D.
  
  
• Stem Cell Research in the Cardiac Field: Where Are We Now? 79
  Jason Griffeth and Kristen Cornella
  
  
• Stem Cell Treatment and Models for Blood Disorders 85
  Linzhao Cheng, Ph.D.
  
  
• Stem Cells and Cancer: A Paradigm Shift 90
  Lynn M Opdenaker, Ph.D., Jeremy Fields, Ph.D., and Bruce M. Boman, M.D., Ph.D.
  
  
• Mimicking Extracellular Matrix to Direct Stem Cell Differentiation 97
  Jennifer Elisseeff, Ph.D. and Tara Deans, Ph.D.
  
  
• Aging: Can Piecemeal Preventative Maintenance Work? 101
  Aubrey D.N.J. de Grey, Ph.D.

• Commitment, Collaboration and Competition in States Funding to Support Stem Cell Research 105
  Dan Gincel, Ph.D.

• Governor Martin O'Malley: Charting Maryland's Bioscience Future 109

• The University of Maryland School of Medicine Center For Stem Cell Biology and Regenerative Medicine: A Synergistic Initiative to Move Stem Cells From Bench to Bedside 113
  Curt I. Civin, M.D.

• Stem Cell Research and the Johns Hopkins Institute for Cell Engineering 117
  Chi Dang, Ph.D.

• Stem Cell Research at the Hugo W. Moser Research Institute at Kennedy Krieger 122
  Michael J. Shamblott, Ph.D.

• Can Stem Cell Innovation Survive In The “New Normal” Economy? 127
  Peter Winter

• Creating Partnerships With Large Pharma? Getting Ready For The Big Day 131
  Devyn Smith, Ph.D.

• Platform Technologies in Regenerative Medicine: Maximizing the Technology Early in the Process 139
  Barbara Nelsen, Ph.D., M.B.A.

• Stem Cell Law, Regulation and Intellectual Property: A Fundamental Pillar of Success 145
  Sam S. Woodley, Ph.D., Esq. and Peter Ludwig, Esq.

• Commercial Manufacturing of Cell Therapy Products – Considering the Options? 150
  Scott R. Burger, M.D.

• Creating an Effective Clinical Delivery Plan for Cell Therapies 155
  Alain Vertes, Ph.D., M.B.A.

• From the Lab to the Market: Coverage and Reimbursement Knowledge is Critical to Stem Cell and Regenerative Medicine Technology Development 162
  Tim Hunter

• Stem Cell Banking – the Growth of Public and Private Cord Blood Banks 168
  Toby Hamblin

• Stem Cell Preservation and Insurance Coverage: Combining Business Leverage for the Stem Cell Industry and New Opportunities in Biobanking 173
  Amnon Pelz

• If You're Breathing, You're in PR
  Lee Buckler 178

• A World of Difference: International Collaboration in Stem Cell Science 184
  Joe Sornberger